Wolverine Trading, LLC Incyte Corp Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $51,597 - $61,749	900 Added 3.47%	26,800 $1.77 Million
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $716,520 - $892,500	14,000 Added 117.65%	25,900 $1.57 Million
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $418,470 - $492,766	7,400 Added 164.44%	11,900 $677,000
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $125,183 - $154,056	-2,400 Reduced 34.78%	4,500 $282,000
Q3 2023 Nov 15, 2023	BUY	$57.77 - $65.93 $202,195 - $230,755	3,500 Added 102.94%	6,900 $398,000
Q2 2023 Aug 23, 2023	BUY	$60.95 - $75.51 $207,230 - $256,734	3,400 New	3,400 $211,000
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $46,214 - $55,796	700 Added 3.89%	18,700 $1.49 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $259,694 - $303,851	-4,100 Reduced 18.55%	18,000 $1.33 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $460,089 - $562,934	6,700 Added 43.51%	22,100 $1.52 Million
Q2 2021 Aug 06, 2021	BUY	$79.87 - $87.53 $702,856 - $770,264	8,800 Added 133.33%	15,400 $1.3 Million
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $1.17 Million - $1.55 Million	-15,400 Reduced 70.0%	6,600 $530,000
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $1.13 Million - $1.37 Million	-14,000 Reduced 38.89%	22,000 $1.91 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $901,741 - $1.16 Million	10,600 Added 41.73%	36,000 $3.15 Million
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $1.46 Million - $2.15 Million	-19,700 Reduced 43.68%	25,400 $2.6 Million
Q1 2020 May 11, 2020	SELL	$63.18 - $85.97 $410,670 - $558,805	-6,500 Reduced 12.6%	45,100 $3.26 Million
Q4 2019 Feb 12, 2020	SELL	$73.04 - $95.72 $51,128 - $67,004	-700 Reduced 1.34%	51,600 $4.54 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $240,305 - $285,516	3,300 Added 6.73%	52,300 $3.81 Million
Q2 2019 Aug 20, 2019	BUY	$73.52 - $88.7 $1.1 Million - $1.33 Million	15,000 Added 44.12%	49,000 $4.16 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $444,920 - $617,190	7,000 Added 25.93%	34,000 $2.92 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $567,450 - $678,418	-9,700 Reduced 26.43%	27,000 $1.68 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $1.16 Million - $1.4 Million	-18,800 Reduced 33.87%	36,700 $2.54 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $473,442 - $575,586	-5,700 Reduced 9.31%	55,500 $4.63 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $1.93 Million - $2.4 Million	20,600 Added 50.74%	61,200 $5.8 Million
Q3 2017 Nov 15, 2017	BUY	$109.15 - $138.27 $4.43 Million - $5.61 Million	40,600	40,600 $4.74 Million

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account